Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Active not recruiting 2Recruiting 1Completed 1

Sponsor Class

NIH 1NETWORK 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Squamous Cell Carcinoma of Head and Neck 12Prostatic Neoplasms 12Oropharyngeal Neoplasms 12Head and Neck Neoplasms 7Carcinoma, Squamous Cell 6Nasopharyngeal Carcinoma 5Esophageal Neoplasms 5Rectal Neoplasms 4Mouth Neoplasms 4Laryngeal Neoplasms 4Glioma 3Carcinoma, Non-Small-Cell Lung 3Breast Neoplasms 3Uterine Cervical Neoplasms 2Salivary Gland Neoplasms 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Papillomavirus Infections 2Oligodendroglioma 2Myelodysplastic Syndromes 2Lymphatic Metastasis 2Leukemia, Myeloid, Acute 2Hypopharyngeal Neoplasms 2Glioblastoma 2Esophageal Squamous Cell Carcinoma 2Carcinoma, Intraductal, Noninfiltrating 2Carcinoma 2Astrocytoma 2Anus Neoplasms 2Virus Diseases 1Vaginal Neoplasms 1

Interventions

Mitomycin 5Specimen Handling 4Nivolumab 4Magnetic Resonance Spectroscopy 4Fluorouracil 4Capecitabine 4Biopsy 4pembrolizumab 3Drug Therapy 3dehydroftorafur 2Vaccines 2Sigmoidoscopy 2Radiotherapy, Intensity-Modulated 2Radiation 2Proctoscopy 2Mitozytrex 2Fluorodeoxyglucose F18 2Colonoscopy 2tislelizumab 1spartalizumab 1entinostat 1durvalumab 1bintrafusp alfa protein, human 1X-Rays 1Watchful Waiting 1Vaccines, Synthetic 1Tomography, X-Ray Computed 1Taxes 1Surveys and Questionnaires 1Sentinel Lymph Node Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Active not recruiting × Anus Neoplasms × Radiotherapy, Intensity-Modulated × Clear all
NCT04929028 2026-05-13

Therapy Adapted for High Risk and Low Risk HIV-Associated Anal Cancer

National Cancer Institute (NCI)

Phase 2 Active not recruiting
40 enrolled
Gastrointestinal

Anus Neoplasms, Rectal Neoplasms, HIV Infections

NCT04166318 2026-05-05

Lower-Dose Chemoradiation in Treating Patients With Early-Stage Anal Cancer, the DECREASE Study

Eastern Cooperative Oncology Group

Phase 2 Active not recruiting
252 enrolled
Gastrointestinal

Anal Canal Carcinoma, Anus Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡